TrialBMC cancer2019

Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer.

Daisuke Kotani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.